Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Brockstein

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2019
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM modelR Chugh, K A Griffith, E J Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2015
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM modelR Chugh, K A Griffith, E J Davis, et al.
Journal of the American College of Surgeons|July 10, 2001
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancerS F Sener, S Milos, J L Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neckB Brockstein, D J Haraf, K Stenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancerM S Kies, D J Haraf, F Rosen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceB Brockstein, D J Haraf, A W Rademaker, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Head and Neck CancersD G Pfister, K Ang, B Brockstein, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2019
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM modelR Chugh, K A Griffith, E J Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2015
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM modelR Chugh, K A Griffith, E J Davis, et al.
Journal of the American College of Surgeons|July 10, 2001
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancerS F Sener, S Milos, J L Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neckB Brockstein, D J Haraf, K Stenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancerM S Kies, D J Haraf, F Rosen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceB Brockstein, D J Haraf, A W Rademaker, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Head and Neck CancersD G Pfister, K Ang, B Brockstein, et al.
Pageof 2